BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
4.770
-0.120 (-2.45%)
At close: Sep 18, 2026, 4:00 PM EDT
4.834
+0.064 (1.34%)
After-hours: Sep 18, 2026, 7:30 PM EDT
BBOT Market Cap
BBOT has a market cap or net worth of $382.43 million as of September 18, 2026. Its market cap has decreased by -55.25% in one year.
Market Cap
382.43M
Enterprise Value
40.82M
1-Year Change
-55.25%
Ranking
Category
Stock Price
$4.77
ChartMarket Cap Chart
Since February 9, 2024, BBOT's market cap has increased from $38.21M to $382.43M, an increase of 900.80%. That is a compound annual growth rate of 141.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 382.43M | -61.81% |
| Dec 31, 2025 | 1.00B | 305.70% |
| Dec 31, 2024 | 246.84M | 545.98% |
| Feb 9, 2024 | 38.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ARS Pharmaceuticals | 408.73M |
| Rezolute | 401.15M |
| Larimar Therapeutics | 395.61M |
| vTv Therapeutics | 395.11M |
| Galectin Therapeutics | 392.31M |
| Benitec Biopharma | 384.41M |
| Fennec Pharmaceuticals | 372.41M |
| Rocket Pharmaceuticals | 369.94M |